Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 251–275 of 566 matching trials (filtered from 7,816) · page 11 of 23, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
A Virtual Reality Mindfulness Application for Aggression in Schizophrenia NCT07434479 Mindfulness-Based Virtual Reality Intervention Runs in: United States · 2 sites |
NA other |
RECRUITING | 58 | Manhattan Psychiatric Center OTHER |
2026-06-10 |
|
Investigation of Inflammation in Alzheimer's Disease and Related Dementias (ADRD) Using [11C]-CS1P1 NCT06129838 [11C]-CS1P1 Runs in: United States · 1 site |
NA other |
RECRUITING | 80 | Washington University School of Medicine OTHER |
2026-06-09 |
|
Beta Amyloid PET Imaging for Alzheimer Disease With [18F]-Fluselenamyl NCT06439992 18F-Fluselenamyl Runs in: United States · 1 site |
NA other |
RECRUITING | 60 | Washington University School of Medicine OTHER |
2026-06-09 |
|
VOCALE LBD: Online Peer Support for Caregivers of People With Lewy Body Dementia NCT07637097 VOCALE LBD: Virtual Online Communities for Aging Life Experiences: ... Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 220 | University of Washington OTHER |
2026-06-09 |
|
F 18 T807 Tau PET Imaging of Alzheimer's Disease NCT02414347 F 18 T807 Runs in: United States · 1 site |
NA other |
RECRUITING | 900 | Tammie L. S. Benzinger, MD, PhD OTHER |
2026-06-08 |
|
Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND) NCT04579120 [11C]-Pittsburgh Compound B ([11C]PiB); F 18 AV-1451 (Flortaucipir) Runs in: United States · 1 site |
NA other |
RECRUITING | 650 | Tammie L. S. Benzinger, MD, PhD OTHER |
2026-06-08 |
|
Manage Emotions to Reduce Aggression (MERA) NCT04793776 Manage Emotions to Reduce Aggression; Present Centered Psychotherapy Runs in: United States · 2 sites |
NA other |
RECRUITING | 204 | VA Office of Research and Development OTHER_GOV |
2026-06-08 |
|
Depression and Driving NCT05446805 F 18 AV-1451 (Flortaucipir); [11C]-Pittsburgh Compound B ([11C]PiB) Runs in: United States · 1 site |
NA other |
RECRUITING | 150 | Washington University School of Medicine OTHER |
2026-06-08 |
|
Biomarker-based Trial of NPC-1 for Alzheimer's Pathology NCT07236190 natural product combination-1 (NPC1) Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 40 | Massachusetts General Hospital OTHER |
2026-06-08 |
|
Resilient Together for Dementia (RT-D) NCT06619327 Resilient Together for Dementia; MEUC Runs in: United States · 1 site |
NA other |
RECRUITING | 24 | Icahn School of Medicine at Mount Sinai OTHER |
2026-06-04 |
|
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD) NCT06657768 LY4006895; Placebo Runs in: Japan; United States · 13 sites |
PHASE1 other |
RECRUITING | 128 | Eli Lilly and Company INDUSTRY |
2026-06-04 |
|
Crownlands Observing Progression With Neurons Study NCT07611396 Runs in: United States · 1 site |
NA other |
RECRUITING | 160 | Crownlands INDUSTRY |
2026-06-04 |
|
Effects of Binaural Beats and Spatialized Music on Behavioural and Psychological Symptoms of Dementia in Assisted Living Facility Residents NCT07626944 Personalized Music Listening (PML); Binaural Beat Music (BBM); Spat... Runs in: United States · 2 sites |
NA other |
RECRUITING | 120 | Maharishi International University OTHER |
2026-06-04 |
|
Telehealth-Adapted Compensatory Training and Intervention for Cognition NCT07366346 Motivationally Enhanced Compensatory Cognitive Training for Mild Co... Runs in: United States · 1 site |
NA other |
RECRUITING | 100 | University of Florida OTHER |
2026-06-03 |
|
Cereset Research for Caregivers NCT05209438 Cereset Research Runs in: United States · 1 site |
NA other |
RECRUITING | 20 | Wake Forest University Health Sciences OTHER |
2026-06-01 |
|
Communication Bridge 3 Study NCT06191198 Communication Bridge™; Evidence-Based Impairment Focused Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 200 | University of Chicago OTHER |
2026-06-01 |
|
Train Your Brain Fitness SC: An Exercise Intervention for People With Cognitive Impairments NCT06799429 Supervised Exercise and Behavior Modification Support; Monitored Ex... Runs in: United States · 2 sites |
NA other |
RECRUITING | 50 | University of South Carolina OTHER |
2026-06-01 |
|
Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients NCT05016219 Circadian-Effective Light; Rhythmic Light; Placebo Light; Placebo R... Runs in: United States · 2 sites |
NA other |
RECRUITING | 120 | Icahn School of Medicine at Mount Sinai OTHER |
2026-05-29 |
|
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease NCT05949047 Cognitive Emotion Regulation Training via Psychological Distancing;... Runs in: United States · 1 site |
NA other |
RECRUITING | 270 | Bryan Denny OTHER |
2026-05-29 |
|
The INSPIRE -Faith Study: Intervention Strategies for Preserving Intellectual Resilience and Engagement NCT06741865 Lifestyle Intervention; Standard Health Education Runs in: United States · 1 site |
NA other |
RECRUITING | 2,000 | Healthy Minds Initiative OTHER |
2026-05-28 |
|
Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease. NCT06781333 hMSC Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 8 | Bernard (Barry) Baumel OTHER |
2026-05-28 |
|
Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease. NCT07512362 human Mesenchymal Stem Cells Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 10 | Bernard (Barry) Baumel OTHER |
2026-05-28 |
|
TREAD: Time Restricted Eating Intervention for Alzheimer's Disease NCT06548191 Time-restricted eating Runs in: United States · 1 site |
PHASE1 other |
RECRUITING | 60 | University of California, San Diego OTHER |
2026-05-26 |
|
[18F]PI-2620 Phase 3 Histopathological Study NCT05641688 [18F]PI-2620 Runs in: United States · 25 sites |
PHASE3 other |
RECRUITING | 200 | Lantheus Biosciences Ltd. INDUSTRY |
2026-05-22 |
|
Brain Stimulation and Cognitive Training for MCI NCT07526740 Accelerated iTBS; Computerized Cognitive Training; Sham Computerize... Runs in: United States · 1 site |
NA other |
RECRUITING | 50 | Medical University of South Carolina OTHER |
2026-05-22 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
Last updated
From the research library
The highest-scoring studies we hold on this subject, each summarized in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial